# FORWARD PRO Study Interventional Post-market Study With the Evolut™ PRO System

> **NCT03417011** · — · COMPLETED · sponsor: **Medtronic Cardiovascular** · enrollment: 638 (actual)

## Conditions studied

- Aortic Valve Stenosis

## Interventions

- **DEVICE:** Medtronic CoreValve™ Evolut™ PRO System (Evolut™ PRO System)

## Key facts

- **NCT ID:** NCT03417011
- **Lead sponsor:** Medtronic Cardiovascular
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-26
- **Primary completion:** 2019-03-06
- **Final completion:** 2024-02-26
- **Target enrollment:** 638 (ACTUAL)
- **Last updated:** 2025-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03417011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03417011, "FORWARD PRO Study Interventional Post-market Study With the Evolut™ PRO System". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03417011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*